Novelix Pharmaceuticals Limited (BOM:536565)
India flag India · Delayed Price · Currency is INR
69.00
-1.05 (-1.50%)
At close: Nov 16, 2026

Novelix Pharmaceuticals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,5521,323307.3345.3119.289.13
Revenue Growth
82.85%330.60%578.26%135.96%-78.45%-7.01%
Gross Profit
83.1254.7811.436.865.386.18
Operating Income
57.6934.31.220.38-0.58-4.82
Net Income
46.5825.570.850.1-0.6-20.27
Earnings Per Share
1.661.210.080.01-0.07-2.50
EPS Growth
118.59%1327.77%749.24%---

Revenue by Segment

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '25 Mar '24 Mar '23 Mar '22
Pharma Business
1,323295.091.452.1378.55
Finance
-0.162.042.732.98
Trading in Shares
-12.0941.1511.917.56
Total
1,323307.3445.3119.291.63

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
32.1529.596.7934.9131.6630.09
Total Debt
65.26----1.65
Net Cash (Debt)
-33.1229.596.7934.9131.6628.44
Net Cash Growth
-335.99%-80.56%10.26%11.31%22.18%
Net Cash Per Share
-1.181.400.683.353.913.51

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-303.3-223.89-136.85-3.43-24.0515.86
Capital Expenditures
-58.47-32.56-1.06--0.04-17.98
Free Cash Flow
-361.77-256.45-137.91-3.43-24.1-2.12
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
5.35%4.14%3.72%15.14%27.99%6.94%
Operating Margin
3.72%2.59%0.40%0.85%-3.04%-5.41%
Pretax Margin
3.54%2.57%0.40%0.47%-3.05%-22.83%
Profit Margin
3.00%1.93%0.27%0.23%-3.12%-22.74%
FCF Margin
-23.30%-19.38%-44.87%-7.58%-125.49%-2.38%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
42.2443.49313.341337.29--
PS Ratio
1.280.840.863.073.800.81